Revvity (RVTY) analyst forecast and price target
Analyst forecast
Consensus of 20 analyst ratings
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| Evercore ISI Group | Maintained | Outperform | $126.00 from $125.00 | Aug 5, 2026 |
| Evercore ISI Group | Maintained | Outperform | $125.00 from $110.00 | Jul 6, 2026 |
| Bernstein | Maintained | Market Perform | $115.00 | Jun 26, 2026 |
| Wolfe Research | Initiated Coverage | Peer Perform | — | Jun 2, 2026 |
| Barclays | Maintained | Equal-Weight | $105.00 from $95.00 | May 7, 2026 |
| Stifel | Maintained | Hold | $100.00 from $110.00 | May 6, 2026 |
| TD Cowen | Maintained | Buy | $120.00 from $115.00 | May 6, 2026 |
| JP Morgan | Maintained | Neutral | $90.00 from $96.00 | May 6, 2026 |
| Baird | Maintained | Outperform | $125.00 from $129.00 | May 4, 2026 |
| Barclays | Downgraded | Overweight → Equal-Weight | $95.00 from $118.00 | Apr 14, 2026 |
| Goldman Sachs | Maintained | Neutral | $95.00 from $110.00 | Apr 14, 2026 |
| JP Morgan | Maintained | Neutral | $96.00 from $105.00 | Mar 31, 2026 |
| Jefferies | Maintained | Hold | $105.00 from $100.00 | Feb 3, 2026 |
| Barclays | Maintained | Overweight | $118.00 from $115.00 | Feb 3, 2026 |
| Wells Fargo | Maintained | Equal-Weight | $110.00 from $107.00 | Feb 3, 2026 |
| Evercore ISI Group | Maintained | Outperform | $118.00 from $112.00 | Feb 3, 2026 |
| TD Cowen | Maintained | Buy | $124.00 from $120.00 | Feb 3, 2026 |
| JP Morgan | Maintained | Neutral | $105.00 from $100.00 | Feb 3, 2026 |
| Wells Fargo | Maintained | Equal-Weight | $107.00 from $102.00 | Dec 15, 2025 |
| Barclays | Maintained | Overweight | $115.00 from $105.00 | Dec 15, 2025 |
Frequently asked questions
Is RVTY a buy, sell, or hold?
Analysts covering Revvity currently average a Hold rating: 7 buy, 13 hold and 0 sell, from 20 analysts. Ratings reflect analyst opinion, not investment advice.
What is the latest analyst rating on RVTY?
On Aug 5, 2026, Evercore ISI Group maintained Revvity at Outperform with a price target of $126.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.